State-dependent changes in hippocampal grey matter in depression

Molecular Psychiatry

Volumn 18, Issue 12, 2013, Pages 1265-1272

  Arnone, D ^a   Mckie, S ^a   Elliott, R ^a   Juhasz, G ^a,b   Thomas, E J ^a   Downey, D ^a   Williams, S ^a   Deakin, J F W ^a   Anderson, I M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

affective disorders; depression; hippocampus; limbic regions; MRI

Indexed keywords

CITALOPRAM;

ADULT; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICATION COMPLIANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PRIORITY JOURNAL; REMISSION; VOXEL BASED MORPHOMETRY;

ADULT; BRAIN; CASE-CONTROL STUDIES; CITALOPRAM; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HIPPOCAMPUS; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; SEROTONIN UPTAKE INHIBITORS;

EID: 84888286733     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2012.150     Document Type: Article

References (71)

1. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology 2011; 35: 192-216.
2. Arnone D, McIntosh AM, Ebmeier KP, Munafo MR, Anderson IM. Magnetic resonance imaging studies in unipolar depression: Systematic review and metaregression analyses. Eur Neuropsychopharmacol 2011; 22: 1-16.
3. Kempton MJ, Salvador Z, Munafo MR, Geddes JR, Simmons A, Frangou S et al. Structural neuroimaging studies in major depressive disorder. Meta-Analysis and comparison with bipolar disorder. Arch Gen Psychiatry 2011; 68: 675-690.
4. Bora E, Fornito A, Pantelis C, Yucel M. Gray matter abnormalities in major depressive disorder: A meta-Analysis of voxel based morphometry studies. J Affect Disord 2011; 138: 9-18.
5. Tang Y, Wang F, Xie G, Liu J, Li L, Su L et al. Reduced ventral anterior cingulate and amygdala volumes in medication-naive females with major depressive disorder: A voxel-based morphometric magnetic resonance imaging study. Psychiat Res 2007; 156: 83-86.
6. Vasic N, Walter H, Hose A, Wolf RC. Gray matter reduction associated with psychopathology and cognitive dysfunction in unipolar depression: A voxel-based morphometry study. J Affect Disord 2008; 109: 107-116.
7. Frodl T, Koutsouleris N, Bottlender R, Born C, Jager M, Morgenthaler M et al. Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Mol Psychiatry 2008; 13: 1093-1101.
8. Wagner G, Koch K, Schachtzabel C, Schultz CC, Sauer H, Schlosser RG. Structural brain alterations in patients with major depressive disorder and high risk for suicide: Evidence for a distinct neurobiological entity? NeuroImage 2011; 54: 1607-1614.
9. Zou K, Deng W, Li T, Zhang B, Jiang L, Huang C et al. Changes of brain morphometry in first-episode, drug-naive, non-late-life adult patients with major depression: An optimized voxel-based morphometry study. Biol Psychiatry 2009; 67: 186-188.
10. Reagan LP, McEwen BS. Controversies surrounding glucocorticoid-mediated cell death in the hippocampus. J Chem Neuroanat 1997; 13: 149-167.
11. Cameron HA, Tanapat P, Gould E. Adrenal steroids and N-methyl-D-Aspartate receptor activation regulate neurogenesis in the dentate gyrus of adult rats through a common pathway. Neuroscience 1998; 82: 349-354.
12. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 2000; 48: 766-777.
13. Scheuerecker J, Meisenzahl EM, Koutsouleris N, Roesner M, Schopf V, Linn J et al. Orbitofrontal volume reductions during emotion recognition in patients with major depression. J Psychiatry Neurosci 2010; 35: 311-320.
14. Chen CH, Ridler K, Suckling J, Williams S, Fu CH, Merlo-Pich E et al. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry 2007; 62: 407-414.
15. Salvadore G, Nugent AC, Lemaitre H, Luckenbaugh DA, Tinsley R, Cannon DM et al. Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. NeuroImage 2010; 54: 2643-2651.
16. Cheng YQ, Xu J, Chai P, Li HJ, Luo CR, Yang T et al. Brain volume alteration and the correlations with the clinical characteristics in drug-naive first-episode MDD patients: A voxel-based morphometry study. Neurosci Lett 2010; 480: 30-34.
17. Lai CH, Hsu YY. A subtle grey-matter increase in first-episode, drug-naive major depressive disorder with panic disorder after 6 weeks duloxetine therapy. Int J Neuropsychopharmacol 2011; 14: 225-235.
18. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59: 1116-1127.
19. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000; 20: 9104-9110.
20. Perera TD, Lisanby SH. Neurogenesis and depression. J Psychiatr Pract 2000; 6: 322-333.
21. Duman RS. Depression: A case of neuronal life and death? Biol Psychiatry 2004; 56: 140-145.
22. Lavretsky H, Roybal DJ, Ballmaier M, Toga AW, Kumar A. Antidepressant exposure may protect against decrement in frontal gray matter volumes in geriatric depression. J Clin Psychiatry 2005; 66: 964-967.
23. Campbell S, Macqueen G. The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci 2004; 29: 417-426.
24. Frodl TS, Koutsouleris N, Bottlender R, Born C, Jager M, Scupin I et al. Depressionrelated variation in brain morphology over 3 years: Effects of stress? Arch Gen Psychiatry 2008; 65: 1156-1165.
25. Ashburner J, Friston KJ. Voxel-based morphometry-The methods. NeuroImage 2000; 11(6 Pt 1): 805-821.
26. First MB, Spitzer RL, Gibbon M, Williams JBW. Structural Clinical Interview for DSMIV-TR Axis I Disorders, Reserach Version, Non-Patient Edition. (SCID-I/NP). Department of Biometric Research, New York State Psychiatric Institute: New York:, 2002.
27. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
28. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-55.
29. Ammons RB, Ammons CH. The Quick Test (QT) - Provisional ManualPsychol Rep 1962; 11: 111-161.
30. WMA. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects World Medical Association 2000. http://www.wma.net/en/ 30publications/10policies/b3/index.html.
31. Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage 2007; 38: 95-113.
32. Ridgway GR, Omar R, Ourselin S, Hill DL, Warren JD, Fox NC. Issues with threshold masking in voxel-based morphometry of atrophied brains. NeuroImage 2009; 44: 99-111.
33. Easy Volume L. Easy Volume. (cited; available from: Http://www.sbirc.ed. ac.uk/LCL/LCL-M1.html).
34. Hayasaka S, Phan KL, Liberzon I, Worsley KJ, Nichols TE. Nonstationary cluster-size inference with random field and permutation methods. NeuroImage 2004; 22: 676-687.
35. Inkster B, Rao AW, Ridler K, Nichols TE, Saemann PG, Auer DP et al. Structural brain changes in patients with recurrent major depressive disorder presenting with anxiety symptoms. J Neuroimaging 2010; 21: 375-382.
36. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15: 273-289.
37. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003; 19: 1233-1239.
38. Maldjian JA, Laurienti PJ, Burdette JH. Precentral gyrus discrepancy in electronic versions of the Talairach atlas. Neuroimage 2004; 21: 450-455.
39. Maldjian JA, Laurienti PJ, Burdette JH, Kraft RA. Clinical implementation of spintag perfusion magnetic resonance imaging. J Comput Assist Tomogr 2008; 32: 403-406.
40. Nordanskog P, Dahlstrand U, Larsson MR, Larsson EM, Knutsson L, Johanson A. Increase in hippocampal volume after electroconvulsive therapy in patients with depression: A volumetric magnetic resonance imaging study. J ECT 2010; 26: 62-67.
41. Lai CH, Hsu YY, Wu YT. First episode drug-naive major depressive disorder with panic disorder: Gray matter deficits in limbic and default network structures. Eur Neuropsychopharmacol 2010; 20: 676-682.
42. MacQueen GM, Ramakrishnan K, Ratnasingan R, Chen B, Young LT. Desipramine treatment reduces the long-Term behavioural and neurochemical sequelae of early-life maternal separation. Inte J Neuropsychopharmacol 2003; 6: 391-396.
43. Young LT, Bakish D, Beaulieu S. The neurobiology of treatment response to antidepressants and mood stabilizing medications. J Psychiatry Neurosci 2002; 27: 260-265.
44. Stewart RJ, Chen B, Dowlatshahi D, MacQueen GM, Young LT. Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium. Brain Res Bull 2001; 55: 625-629.
45. Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 1998; 352: 1754-1755.
46. Aydemir O, Deveci A, Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: A preliminary study. Prog Neuro-Psych Biol Psych 2005; 29: 261-265.
47. Schermuly I, Wolf D, Lieb K, Stoeter P, Fellgiebel A. State dependent posterior hippocampal volume increases in patients with major depressive disorder. J Affect Disord 2011; 135: 405-409.
48. Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry 2003; 160: 1516-1518.
49. Arnone D, McKie S, Elliott R, Thomas EJ, Downey D, Juhasz G et al. Increased amygdala responses to sad but not fearful faces in major depression: Relation to mood state and pharmacological treatment. Am J Psychiatry 2012; 169: 841-850.
50. Montag C, Basten U, Stelzel C, Fiebach CJ, Reuter M. The BDNF Val66Met polymorphism and anxiety: Support for animal knock-in studies from a genetic association study in humans. Psychiat Res 2010; 179: 86-90.
51. Juhasz G, Dunham JS, McKie S, Thomas E, Downey D, Chase D et al. The CREB1-BDNF-NTRK2 pathway in depression: Multiple gene-cognition-environment interactions. Biol Psychiatry 2011; 69: 762-771.
52. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry 2003; 54: 515-528.
53. Bell-McGinty S, Butters MA, Meltzer CC, Greer PJ, Reynolds III CF, Becker JT. Brain morphometric abnormalities in geriatric depression: Long-Term neurobiological effects of illness duration. Am J Psychiatry 2002; 159: 1424-1427.
54. Kim MJ, Hamilton JP, Gotlib IH. Reduced caudate gray matter volume in women with major depressive disorder. Psychiat Res 2008; 164: 114-122.
55. Abe O, Yamasue H, Kasai K, Yamada H, Aoki S, Inoue H et al. Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression. Psychiat Res 2010; 181: 64-70.
56. Bergouignan L, Chupin M, Czechowska Y, Kinkingnehun S, Lemogne C, Le Bastard G et al. Can voxel based morphometry, manual segmentation and automated segmentation equally detect hippocampal volume differences in acute depression? NeuroImage 2009; 45: 29-37.
57. Mak AK, Wong MM, Han SH, Lee TM. Gray matter reduction associated with emotion regulation in female outpatients with major depressive disorder: A voxel-based morphometry study. Prog Neuro-Psych Biol Psych 2009; 33: 1184-1190.
58. Peng J, Liu J, Nie B, Li Y, Shan B, Wang G et al. Cerebral and cerebellar gray matter reduction in first-episode patients with major depressive disorder: A voxel-based morphometry study. Eur J Radiol 2010; 80: 395-399.
59. Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry 1998; 172: 527-532.
60. Li CT, Lin CP, Chou KH, Chen IY, Hsieh JC, Wu CL et al. Structural and cognitive deficits in remitting and non-remitting recurrent depression: A voxel-based morphometric study. NeuroImage 2010; 50: 347-356.
61. van Tol MJ, van der Wee NJ, van den Heuvel OA, Nielen MM, Demenescu LR, Aleman A et al. Regional brain volume in depression and anxiety disorders. Arch Gen Psychiatry 2010; 67: 1002-1011.
62. Gerritsen L, Comijs HC, van der Graaf Y, Knoops AJ, Penninx BW, Geerlings MI. Depression, hypothalamic pituitary adrenal axis, and hippocampal and entorhinal cortex volumes-The SMART Medea study. Biol Psychiatry 2011; 70: 373-380.
63. Surget A, Tanti A, Leonardo ED, Laugeray A, Rainer Q, Touma C et al. Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry 2011; 16: 1177-1188.
64. Chen MC, Hamilton JP, Gotlib IH. Decreased hippocampal volume in healthy girls at risk of depression. Arch Gen Psychiatry 2010; 67: 270-276.
65. Voormolen EH, Wei C, Chow EW, Bassett AS, Mikulis DJ, Crawley AP. Voxel-based morphometry and automated lobar volumetry: The trade-off between spatial scale and statistical correction. NeuroImage 2010; 49: 587-596.
66. Mevel K, Desgranges B, Baron JC, Landeau B, de La Sayette V, Viader F et al. Which SPM method should be used to extract hippocampal measures in early Alzheimers disease? J Neuroimaging 2011; 21: 310-316.
67. Groves JO. Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 2007; 12: 1079-1088.
68. Obergriesser T, Ende G, Braus DF, Henn FA. Long-Term follow-up of magnetic resonance-detectable choline signal changes in the hippocampus of patients treated with electroconvulsive therapy. J Clin Psychiatry 2003; 64: 775-780.
69. Ende G, Braus DF, Walter S, Weber-Fahr W, Henn FA. The hippocampus in patients treated with electroconvulsive therapy: A proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry 2000; 57: 937-943.
70. Selvaraj S, Arnone D, Job D, Stanfield A, Farrow TF, Nugent AC et al. Grey matter differences in bipolar disorder: A meta-Analysis of voxel-based morphometry studies. Bipolar Disord 2012; 14: 135-145.
71. Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: Meta-Analysis. Br J Psychiatry 2009; 195: 194-201.